InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the complete record of transactions filed by Young James Emmett. Insider active across 1 company, notably TriSalus Life Sciences, Inc.. Cumulatively, 4 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €33k. History available since 27 January 2025. The latest transaction was filed on 19 May 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Young James Emmett is a declarant linked to TriSalus Life Sciences, Inc., where he is Chief Financial Officer. He has 4 filings in total, and among the sampled recent filings from 2025-01-29 to 2025-05-21, the total buy amount is EUR 32682, with no reported sell amount, and the modal transaction nature is Attribution.